Filtered By:
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 2470 results found since Jan 2013.
COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report
CONCLUSION: Given the absence of international agreement on how to manage COVID-19 patients with steroid-dependent VKH, existing clinical guidelines should be reviewed thoroughly to formulate useful strategies for managing VKH patients on steroid treatment who contract COVID-19. Furthermore, the outcomes of patients with steroid-dependent autoimmune uveitis including VKH who develop COVID-19 should be analyzed.PMID:37084286 | DOI:10.1080/09273948.2023.2200488
Source: Ocular Immunology and Inflammation - April 21, 2023 Category: Allergy & Immunology Authors: Shoichiro Niidome Yoshihiko Usui Kinya Tsubota Risa Sugawara Hiroshi Goto Source Type: research
Localised swelling at sites of dermal filler injections following administration of Covid-19 vaccines: a systematic review
CONCLUSION: Rare, self-limiting adverse reactions to dermal fillers have been reported following COVID-19 vaccination. Clinicians should be aware of this clinical phenomenon and its management, as vaccination is carried out globally.PMID:37077055 | DOI:10.4103/singaporemedj.SMJ-2021-157
Source: Singapore Medical Journal - April 20, 2023 Category: General Medicine Authors: Chew Lip Ng Evelyn Yuxin Tay Alwyn Ray D'Souza Source Type: research
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet
More than 3 years after its first appearance, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still among the most troublesome respiratory viruses and the coronavirus disease 2019 (COVID-19) pandemic is still not under control globally [1]. A clear association between dysregulated inflammation and adverse clinical outcomes has been demonstrated in COVID-19 since the very beginning of the pandemic with the so-called "cytokine storm" advocated as the key pathogenetic mechanism in severe disease [2, 3]. The scientific community theorised the use of immunomodulating agents to control this process and, among the...
Source: European Respiratory Journal - April 20, 2023 Category: Respiratory Medicine Authors: Nigro, M., Chalmers, J. D., Aliberti, S. Tags: Editorials Source Type: research
